Carlo Greco

Prof. Greco is the incumbent Director of Clinical Research at the Champalimaud Centre for the Unknown (CCU), a translational cancer research institute based in Lisbon. With his team, he has conducted several research studies of extreme hypofractionation and single-dose radiation therapy in limited oligometastatic disease with PET/CT confirmation of long-term complete response in over 90% of lesions treated with SDRT.